calendar
9,085 catalysts · 3,229 8k filing · 1,811 grant · 1,000 device adverse event · 867 approval · 647 device 510k · 584 earnings
9,085 catalysts · 3,229 8k filing · 1,811 grant · 1,000 device adverse event · 867 approval · 647 device 510k · 584 earnings
Product code: PNZ. Advisory committee: Ear, Nose, Throat. Type: Traditional
Product code: QNQ. Advisory committee: General Hospital. Type: Traditional
Product code: MUJ. Advisory committee: Radiology. Type: Special
Product code: DWF. Advisory committee: Cardiovascular. Type: Traditional
Product code: DYB. Advisory committee: Cardiovascular. Type: Special
Supplement type: 135 Review Track For 30-Day Notice. Product code: PNJ. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: HQL. Advisory committee: OP. Decision: APPR
Supplement type: 135 Review Track For 30-Day Notice. Product code: NIK. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: NIP. Advisory committee: CV. Decision: OK30
Supplement type: 135 Review Track For 30-Day Notice. Product code: LWS. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: LGW. Advisory committee: NE. Decision: APPR
Supplement type: 135 Review Track For 30-Day Notice. Product code: NVN. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: LZD. Advisory committee: DE. Decision: OK30
Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30
Supplement type: 135 Review Track For 30-Day Notice. Product code: NVN. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: NPU. Advisory committee: CV. Decision: APPR
Brand Name: TECNIS Eyhance IOL with TECNIS Simplicity" Delivery System Product Name: TECNIS Eyhance IOL with TECNIS Simplicity" Delivery System Model/Catalog Number: DIB00 Software Version: N/A Product Description: The TECNIS SIMPLICITY" Delivery System is designed to provide a sterile,controlled and touch-free method of delivering the lens into the eye. The lens is preloaded and pre-assembled in the delivery system. The TECNIS SIMPLICITY" Delivery System Model DIB00 contains the TECNISEyhance" IOL, which is a one-piece, foldable, posterior chamber lens with an overall diameter of 13.0 mm and an optic diameter of 6.0 mm. The TECNIS SIMPLICITY" Delivery System is designed to provide a sterile,controlled and touch-free method of delivering the lens into the eye. Component: No — Reason: Due to identifying a limited quantity of intraocular lenses that may have a haptic that sticks to the optic which prevents the lens from unfolding as consistently as expected. — Status: Ongoing
AI grant. $771,210. PI: Denise M Monack
AI grant. $434,938. PI: Lanying Du
AI grant. $250,682. PI: Leonardo D'Aiuto
AI grant. $813,921. PI: Botond Z Igyarto
AI grant. $776,394. PI: Magdalena Maria Gorska
ES grant. $906,000. PI: IRFAN RAHMAN
AI grant. $431,784. PI: ALAN R HAUSER
AI grant. $722,262. PI: Christopher M Jewell
AI grant. $410,864. PI: Cheng Zhu
AI grant. $482,071. PI: ANDREW ALSPAUGH
ES grant. $422,117. PI: Alison Bernstein
AI grant. $571,747. PI: Zhen Lin
AI grant. $496,344. PI: Bernard Khor
AI grant. $414,305. PI: Kelly Keisen Lee
AI grant. $462,052. PI: Insoo Kang
DK grant. $847,495. PI: Macey Leigh Levan
AI grant. $859,278. PI: Bree Beardsley Aldridge
AI grant. $787,498. PI: Glen N. Barber
AI grant. $800,557. PI: JONATHAN C KAGAN
DK grant. $551,250. PI: Jingshi Shen
DA grant. $48,996. PI: Tofunmi Oteju
AI grant. $414,029. PI: Victoria Manuel D'Souza
AI grant. $439,375. PI: Omar Sultan Akbari
AI grant. $815,762. PI: Angela Marie Phillips
AI grant. $756,078. PI: Mingnan Chen
Sponsor: AVYXA HOLDINGS. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: INVAGEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: VANDA PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: GUERBET. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: REMPEX. Form: POWDER. Route: INTRAVENOUS
Sponsor: ADC Therapeutics SA. Form: INJECTABLE. Route: INJECTION
Sponsor: EMERGE BIOSCIENCE. Form: INJECTABLE. Route: INJECTION